Form 4: Verisk Analytics CFO Sells 200 Shares Under 10b5-1 Plan
SEC Form 4 Filing
Verisk Analytics' Chief Financial Officer, Elizabeth Mann, sold 200 shares of common stock at $286.49 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Elizabeth Mann, the Chief Financial Officer of Verisk Analytics, sold 200 shares of the company's common stock on November 15, 2024.
- The sale was executed at a price of $286.49 per share.
- This transaction was conducted under a pre-arranged 10b5-1 trading plan that Ms. Mann had established on December 15, 2023.
- Following the transaction, Ms. Mann directly owns 15,608 shares of Verisk Analytics common stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction under a pre-arranged trading plan, indicating a neutral sentiment. There is no indication of positive or negative implications for the company's performance.
Industry Context
This is a routine filing related to insider trading activity. It is common for executives to use 10b5-1 plans to manage their stock sales and avoid accusations of insider trading.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a standard practice among executives at publicly traded companies, including those in the financial data and analytics sector like Moody's Corporation (MCO) and S&P Global (SPGI).
- These plans allow for pre-scheduled sales of stock, mitigating concerns about trading on non-public information.
- The volume of shares sold is relatively small compared to the total outstanding shares of Verisk Analytics, and is not unusual for routine executive transactions.
Stakeholder Impact
- The sale of shares by a company executive may have a minor impact on shareholder sentiment, but the transaction is not likely to significantly affect the stock price due to the small volume and pre-planned nature.
Key Dates
| Date | Description |
|---|---|
| 12/15/2023 | Date Ms. Mann entered into the 10b5-1 trading plan. |
| 11/15/2024 | Date of the stock sale transaction. |
| 11/18/2024 | Date the Form 4 was signed. |
Keywords
Verisk Analytics, Elizabeth Mann, CFO, stock sale, 10b5-1 plan, insider trading, VRSK
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.